Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...

Cellares will adapt and automate the SBT-77-7101 manufacturing process from Sonoma for use with Cell Shuttle.

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

When Axiom Biosciences' stem cell therapy demonstrated a 0% mortality rate over two years in potentially fatal newborn ...

TAA-T cell therapy left four children with terminal brain cancer in long-term remission, with two new trials now expanding ...

An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now ...

Works For Patients With Cancers Not Treatable With Conventional Methods ...

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

CAR T-cell therapy, a revolutionary cancer treatment known as the living drug, has shown remarkable success in combating ...